neogen presentation april_2011_gl
DESCRIPTION
Company presentation for Genericlicensing.com's featured company of the week (May18th)TRANSCRIPT
Powerpoint Templates
Confidential Presentation – April 2011
(2) No skills or willingness
to undertake developments
(3) Neogen develops
and licenses out
(1) Generic companies
wishing to extend their
portolios
API DEVELOPMENT
FINISHED DOSE DEVELOPMENT
SUBMISSION / REGISTRATION
REGISTRATION FILE COMPILATION
SALES AND MARKETING
2 – 4 years
PRODUCT SELECTION / FEASABILITY Core competence
Market intel, patent search, formulation, risk assessment, lab scale batches, manufacturing facilities (capacity), commercial scale production, stability testing, release and controlled transport, warehousing, regulatory strategy.
SUPPLY / SUPPORT
Development and registrationblow fill seal, lyophilized (freeze dried), standard solutionsdevelopment (usually) performed inhouse production outsourced
located in oa. Greece, Germany, France, India and ItalyFirst mover advantage on several productsFirst product launched
Development and registration Creams and Nasal sprays
Entry hurdle: requirement for clinical testing Performed with external development and production partners in EU
Eric Dubois: 27 years of experience in the pharmaceutical industry including general management of ratiopharm Belgium and responsible of dossier development at Docpharma.
Khaled Dandachi: 28 years of experience in technical development of originator and generic drugs, including for Docpharma, Pfizer, Federa, Aguettant, Merck-Génériques, Lelin.
Thomas Jacobsen: 12 years of experience in the pharmaceutical industry, focused on licensing and business development.
Esther Kranenburg: 9 years of experience in the pharmaceutical industry, focused on licensing and business development. Responsible for licensing for Western Europe and Poland.
Email: [email protected] / Cell: +31 6 2360 1406
Tristram Lake: 9 years of experience in the pharmaceutical industry, focused on licensing and business development. Responsible for licensing for CEE (excluding Poland), CIS, Greece, Israel, Italy, Portugal, Russia, Spain and Turkey.
Email: [email protected] / Phone: +36 1709 2820 / Cell: +36 302 133 497
www.neogen.be